Sun Biomedical (ASX:SBN) 3-Year EBITDA Growth Rate : -20.50% (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Sun Biomedical 3-Year EBITDA Growth Rate?

Sun Biomedical's EBITDA per Share for the six months ended in Dec. 2023 was A$0.00.

During the past 3 years, the average EBITDA Per Share Growth Rate was -20.50% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -18.60% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was -7.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Sun Biomedical was 79.00% per year. The lowest was -77.00% per year. And the median was 4.50% per year.

Competitive Comparison of Sun Biomedical's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, Sun Biomedical's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sun Biomedical's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sun Biomedical's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Sun Biomedical's 3-Year EBITDA Growth Rate falls into.

Sun Biomedical 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Sun Biomedical (ASX:SBN) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Sun Biomedical 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Sun Biomedical's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Sun Biomedical (ASX:SBN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sun Biomedical Ltd (ASX:SBN) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

DXB:Australia

Address

425 Smith Street, Fitzroy, VIC, AUS, 3065

Website

https://www.dimerix.com

Dimerix Ltd is a biopharmaceutical company developing innovative new therapies in areas with unmet medical needs. The company is developing five product candidates: DMX-200 for FSGS; DMX-200 for diabetic kidney disease; DMX-200 for COVID-19 pneumonia patients in ICU; DMX-200 for respiratory complications in Covid-19 patients; and DMX-700 for COPD; as well as the proprietary ReceptorHIT assay technology.

Sun Biomedical (ASX:SBN) Headlines

No Headlines